Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to bring early psychosis care to community clinics

NCT ID NCT06640803

Knowledge-focused Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a stepped-care program to help identify and treat young people (ages 12-25) who are at clinical high risk for psychosis. The program is being rolled out in six community mental health clinics and includes steps like assessment, case management, stress management, and therapy. Researchers will track how many youth enroll and move through the program, and whether their symptoms and functioning improve over two years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Stepped-care including cognitive behavioral case management
What this could lead to
If successful, this could show that a stepped-care approach is a practical way to identify and help youth at risk for psychosis in community settings, potentially improving early intervention.
What could go wrong
This is an early implementation study focused on feasibility and reach, not a direct test of treatment effectiveness. Results may not apply to other settings or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 223 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Clinical High Risk for Psychosis Syndrome as assessed by the mini-SIPS 2. Aged between 12-25 years old 3. Receiving care in one of six identified community mental health clinics 4. Eligibility for Sacramento County Medicare 5. Ability to provide informed consent Exclusion Criteria: 1. Intellectual disability (IQ\<70) 2. Urgent clinical need for a higher level of care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical high risk for psychosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychotic Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clinical high risk for psychosis Ultra high risk for psychosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Capital Star Community Services

    RECRUITING

    Sacramento, California, 95821, United States

  • Heartland Child and Family Services

    RECRUITING

    Sacramento, California, 95838, United States

  • River Oak Center for Children

    RECRUITING

    Elk Grove, California, 95758, United States

  • Turning Point Community Programs

    RECRUITING

    Elk Grove, California, 95758, United States

  • University of California Department of Psychiatry and Behavioral Sciences; Early Psychosis Programs

    RECRUITING

    Sacramento, California, 95817, United States

  • University of California-Davis CAARE Diagnostic and Treatment Center

    RECRUITING

    Sacramento, California, 95820, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.